CP-123,369: a potent, orally active immunosuppressive agent.
Koch
K
K
Central Research Division, Pfizer Inc., Groton, CT 06340, USA.
Hanson
D C
DC
Newborg
M F
MF
Cooper
K
K
Fouda
H G
HG
Biehl
M L
ML
Shepard
R M
RM
Donovan
C B
CB
Biggers
M S
MS
Ramchandani
M
M
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000494:pharmacology
C097667:CP 123369; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016559:Tacrolimus